Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Chen-Hsing Yen"'
Autor:
Singh, Hemindermeet, Mehta, Rajendra H., O'Neill, William, Kapur, Navin K., Lalonde, Thomas, Ohman, Magnus, Ghiu, Ioana, Chen-Hsing, Yen, Dutcheshen, Karey, Schreiber, Theodore, Rosman, Howard, Kaki, Amir
Publikováno v:
In American Heart Journal August 2021 238:66-74
Roll-in Experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) Study
Autor:
Timothy P. Murphy, Joseph I. Shapiro, Kenneth Rosenfield, William L. Henrich, Chen-Hsing Yen, Christopher J. Cooper, RN Holly Burtch, Lance D. Dworkin, Donald E. Cutlip, Diane M. Reid, Joseph M. Massaro, John H. Rundback, Kenneth Jamerson, Claudia C. Thum, A.H. Matsumoto
Publikováno v:
Journal of Vascular and Interventional Radiology. 25:511-520
Purpose To describe the experience and results from the roll-in phase of the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study. Materials and Methods The CORAL roll-in database was used to describe the baseline characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84c21bace5c843de03e4e69b1b20566
https://doi.org/10.1016/j.jvir.2013.09.018
https://doi.org/10.1016/j.jvir.2013.09.018
Autor:
John J. Lopez, Paul H. Tolerico, Ronald P. Caputo, Gaurav Dhar, David Cohen, Neal S. Kleiman, Chen Hsing Yen, Richard G. Bach, Michael J. Pencina, Ankush Goel, Paul C. Gordon, Ron Waksman
Publikováno v:
The American Journal of Cardiology. 110:350-355
In randomized trials, longer drug-eluting stent (DES) length has been associated with adverse clinical events. We used data from the EVENT registry to examine the impact of DES length on outcomes in routine clinical practice. We identified 5,425 unse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53440563dc2cd35591bad0fa6a36df18
https://doi.org/10.1016/j.amjcard.2012.03.031
https://doi.org/10.1016/j.amjcard.2012.03.031
Autor:
Emmanouil S. Brilakis, Michael J. Pencina, Chen Hsing Yen, Jorge F. Saucedo, Peter B. Berger, Subhash Banerjee, Neal S. Kleiman, Deborah Nassif, David Cohen, Michelle J. Keyes, Robert N. Piana
Publikováno v:
American Heart Journal. 161:360-366
The aim of the study was to describe the incidence and consequences of minor surgery after drug-eluting stent (DES) implantation.The Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry prospectively enrolled unselected patients und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da2c38f63a9c748d3a13a7ab3a9f9c8
https://doi.org/10.1016/j.ahj.2010.09.028
https://doi.org/10.1016/j.ahj.2010.09.028
Autor:
Michael J. Pencina, Peter B. Berger, Donald E. Cutlip, Victor Novack, Mirle A. Kellett, Mun K. Hong, Steven L. Goldberg, Ronald Waksman, David J. Cohen, Neal S. Kleiman, Chen Hsing Yen, Albert E. Raizner, Laura Mauri
Publikováno v:
JACC: Cardiovascular Interventions. 2(8):767-775
Objectives The aim of this study was to compare outcomes among unselected patients undergoing percutaneous coronary intervention (PCI) with either sirolimus-eluting (SES) or paclitaxel-eluting stents (PES). Background Although the benefits of both SE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04037e4c3ca6e641b267be6ddd65fbfa
Autor:
Jorge F. Saucedo, Chen-Hsing Yen, John J. Lopez, Faisal Latif, Donald E. Cutlip, David J. Moliterno, Event Investigators, Michael J. Pencina, Neal S. Kleiman, Deborah Nassif, David J. Cohen
Publikováno v:
JACC: Cardiovascular Interventions. 2:37-45
Objectives This study sought to evaluate ischemic and bleeding outcomes in patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Background Previous studies have shown that CKD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8921bbf4f1c941a8989ecc9a01b6018d
https://doi.org/10.1016/j.jcin.2008.06.012
https://doi.org/10.1016/j.jcin.2008.06.012
Autor:
Michelle J. Keyes, Elias B. Hanna, Jorge F. Saucedo, Tarun W. Dasari, David Cohen, Neal S. Kleiman, Chen Hsing Yen
Publikováno v:
The American journal of cardiology. 113(4)
Secondary prevention trials have demonstrated the efficacy of statins in reducing cardiovascular morbidity and mortality in patients with coronary artery disease and events after percutaneous coronary intervention (PCI). However, there are few data d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f97a15c75b02ad2cdf4f22fa5136700
https://pubmed.ncbi.nlm.nih.gov/24342762
https://pubmed.ncbi.nlm.nih.gov/24342762
Autor:
Victor, Novack, Donald, Cutlip, Neal, Kleiman, Michael, Pencina, Laura, Mauri, Chen-Hsing, Yen, Peter, Berger, Steven, Goldberg, Mirle, Kellett, Ronald, Waksman, Mun, Hong, Albert E, Raizner, David J, Cohen
Publikováno v:
JACC. Cardiovascular interventions. 2(8)
The aim of this study was to compare outcomes among unselected patients undergoing percutaneous coronary intervention (PCI) with either sirolimus-eluting (SES) or paclitaxel-eluting stents (PES).Although the benefits of both SES and PES are well-esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63c8042d08e817a881f06dc5e75cc5b4
https://pubmed.ncbi.nlm.nih.gov/19695547
https://pubmed.ncbi.nlm.nih.gov/19695547
Autor:
Faisal, Latif, Neal S, Kleiman, David J, Cohen, Michael J, Pencina, Chen-Hsing, Yen, Donald E, Cutlip, David J, Moliterno, Deborah, Nassif, John J, Lopez, Jorge F, Saucedo
Publikováno v:
JACC. Cardiovascular interventions. 2(1)
This study sought to evaluate ischemic and bleeding outcomes in patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES).Previous studies have shown that CKD is associated with poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8936d3d3224a9c88829fcd205195b8d0
https://pubmed.ncbi.nlm.nih.gov/19463396
https://pubmed.ncbi.nlm.nih.gov/19463396